Cas 890042-57-6,4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid

890042-57-6

Post Buying Request

Basic information

Product Name: 4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid
Synonyms: 4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid
CAS NO:890042-57-6
Molecular Formula:
Molecular Weight: 328.749
EINECS: N/A
Product Categories: N/A
Mol File: 890042-57-6.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid(CAS DataBase Reference)
NIST Chemistry Reference: 4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid(890042-57-6)
EPA Substance Registry System: 4-[4-(3-acetoxy-propoxy)-3-chloro-phenyl]-4-oxo-butyric acid(890042-57-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 890042-57-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

890042-57-6 Suppliers

Recommended suppliersmore

890042-57-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 890042-57-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,0,4 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 890042-57:
(8*8)+(7*9)+(6*0)+(5*0)+(4*4)+(3*2)+(2*5)+(1*7)=166
166 % 10 = 6
So 890042-57-6 is a valid CAS Registry Number.

890042-57-6Upstream product

890042-57-6Downstream Products

890042-57-6Relevant articles and documents

COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE

-

Page/Page column 40-41, (2010/11/08)

This invention provides compounds that possess inhibitory activity against β-adrenergic receptors and phosphodiesterases, including phosphodiesterase 3 (PDE3). This invention further provides pharmaceutical compositions comprising such compounds; methods

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 890042-57-6